D
Sell
3/18/2025Upgraded
TriSalus Life Sciences, Inc. (TLSI) was upgraded to D- from E+ on 3/18/2025 due to an increase in the volatility index and total return index.
E
Sell
3/3/2025Downgrade
TriSalus Life Sciences, Inc. (TLSI) was downgraded to E+ from D- on 3/3/2025 due to a decline in the volatility index and valuation index.
D
Sell
1/10/2025Upgraded
TriSalus Life Sciences, Inc. (TLSI) was upgraded to D- from E+ on 1/10/2025 due to a large increase in the growth index and volatility index. Earnings per share increased from -$0.2147 to -$0.1208, operating cash flow increased 19.18% from -$13.42M to -$10.85M, and EBIT increased 14.4% from -$8.17M to -$7M.
E
Sell
9/26/2024Downgrade
TriSalus Life Sciences, Inc. (TLSI) was downgraded to E+ from D- on 9/26/2024 due to a significant decline in the solvency index, volatility index and total return index.
D
Sell
2/22/2024Upgraded
TriSalus Life Sciences, Inc. (TLSI) was upgraded to D- from E+ on 2/22/2024 due to a significant increase in the solvency index, volatility index and growth index. The quick ratio increased from 0.19 to 2.63, earnings per share increased from -$0.8859 to -$0.1324, and total revenue increased 12.6% from $4.61M to $5.19M.
E
Sell
10/18/2023Downgrade
TriSalus Life Sciences, Inc. (TLSI) was downgraded to E+ from D- on 10/18/2023 due to a large decline in the total return index, volatility index and growth index. Earnings per share declined from -$0.5707 to -$0.8859, and EBIT declined 12.97% from -$10.12M to -$11.43M.
D
Sell
8/24/2023Downgrade
TriSalus Life Sciences, Inc. (TLSI) was downgraded to D- from D on 8/24/2023 due to a decline in the volatility index and total return index.
D
Sell
8/18/2023None
TriSalus Life Sciences, Inc. (TLSI) was downgraded to D from U on 08/18/2023.
